Global Pharmaceutical Excipients Market Report 2022: Market is Expected to Surpass $10 Billion in 2026 - Forecasts to 2031
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Excipients Global Market Report 2022: By Functionality, By Type, By Product" report has been added to ResearchAndMarkets.com''s offering. Major players in the pharmaceutical excipients market are, Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International Plc, Ashland, BASF SE, The Lubrizol Corporation and Roquette Freres. The global pharmaceutical excipients market is expected to grow from $8.13 billion in 2021 to $8.60 billion in 2022 at a compound annual growth rate (CAGR) of 5.9%. The market is expected to reach $10.88 billion in 2026 at a CAGR of 6.0%. The pharmaceutical excipients market consists of sales of pharmaceutical excipients and related services. The excipient is a substance, not an active pharmaceutical ingredient (API) that has been evaluated for safety, and intentionally added in a drug delivery system. Excipient''s major roles are to protect, support, enhance stability, bioavailability, patient acceptability, and assist in the effectiveness.
Global Pharmaceutical Excipients Market Report 2022: Market is Expected to Surpass $10 Billion in 2026 - Forecasts to 2031
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Excipients Global Market Report 2022: By Functionality, By Type, By Product" report has been added to ResearchAndMarkets.com''s offering. Major players in the pharmaceutical excipients market are, Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International Plc, Ashland, BASF SE, The Lubrizol Corporation and Roquette Freres. The global pharmaceutical excipients market is expected to grow from $8.13 billion in 2021 to $8.60 billion in 2022 at a compound annual growth rate (CAGR) of 5.9%. The market is expected to reach $10.88 billion in 2026 at a CAGR of 6.0%. The pharmaceutical excipients market consists of sales of pharmaceutical excipients and related services. The excipient is a substance, not an active pharmaceutical ingredient (API) that has been evaluated for safety, and intentionally added in a drug delivery system. Excipient''s major roles are to protect, support, enhance stability, bioavailability, patient acceptability, and assist in the effectiveness.